Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President Joe Biden’s plan to lower prescription drug cost.
Homebuilders say demand is rising, but they’re concerned about banking fallout
Homebuilder confidence rose in March for the third straight month, but sales expectations over the next six months fell.
Solar stocks Sunrun and Sunnova Energy are at attractive entry points after SVB crisis, Wells Fargo says
The firm said the likelihood of a pause in interest rate hikes from the Federal Reserve is a boon for solar stocks.
College hopefuls have a new ultimate dream school — and it’s not Harvard, Princeton or Yale
As National College Decision Day approaches, most of the colleges at the top of students’ wish lists are among the most selective and most expensive.
Wholesale prices post unexpected decline of 0.1% in February; retail sales fall
The producer price index was expected to increase 0.3% in February, according to Dow Jones estimates.
Four days of panic: How startup execs navigated SVB’s meltdown and prepared for the worst
When SVB failed last week, tech CEOs had a lot to worry about, most immediately how they would make payroll for March 15.
Citi upgrades Truist, says investors are wrong to make ‘apples and oranges’ comparison with SVB
The Wall Street firm said Truist shares can jump 60% after their recent drop.
Mortgage demand rises despite volatile interest rates
Demand for mortgages increased for the second straight week, despite some wide volatility in mortgage rates.
UBS upgrades this regional bank stock that can rally more than 50%
The Wall Street firm said this bank is positioned well for a lower interest rate environment.
UBS upgrades this regional bank stock that can rally more than 50%
The Wall Street firm said this bank is positioned well for a lower interest rate environment.
